Early research (Phase 1)Looking for participantsNCT07205159
What this trial is testing
Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata.
Who this might be right for
Alopecia Areata
Forte Biosciences, Inc. 32